Viral vector-based vaccines are promising candidates that deliver antigens of interest into hosts. Particularly, a single-cycle virus possesses the immunogenicity of a live virus vaccine and safety of an inactivated virus vaccine because they do not produce progeny virion after infection. The rVHSV-GΔTM single-cycle, which removes the transmembrane region and C-terminal cytoplasmic region of the G gene from the KJ2008 isolate, virus demonstrates its superiority as a vaccine in controlling the viral hemorrhagic septicemia virus (VHSV) in olive flounder, although research for establishing its suitability is still lacking. Therefore, we established optimal usage through various concentrations and booster immunizations in olive flounder and confirmed the cross-protective effect against KJ2008 and GCVP-02 belonging to different subclades of the glycoprotein genotype IVa. The olive flounder were intramuscular prime or boost immunized from 1 × 102 pfu/fish to 1 × 104 pfu/fish of rVHSV-GΔTM. After four weeks of immunization, each group was challenged with KJ2008 and GCVP-02 isolates. In the prime immunization group, protective efficacy against the GCVP-02 isolate was relatively low compared with the KJ2008 isolate, but the boost immunization group showed improved protective efficacy in both isolates. Our findings suggest that the rVHSV-GΔTM single-cycle virus vaccine based on the KJ2008 isolate can be effective in controlling VHSV in the fish culture industry because it showed a protective efficacy even against other isolates and high protective efficacy upon boosting.
Read full abstract